Compare TFIN & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TFIN | INSP |
|---|---|---|
| Founded | 1981 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2018 |
| Metric | TFIN | INSP |
|---|---|---|
| Price | $70.15 | $41.21 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 16 |
| Target Price | $66.20 | ★ $94.00 |
| AVG Volume (30 Days) | 195.0K | ★ 1.3M |
| Earning Date | 04-21-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $7.27 | $8.02 |
| Revenue Next Year | $11.31 | $8.11 |
| P/E Ratio | $66.31 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $46.43 | $39.61 |
| 52 Week High | $77.84 | $147.03 |
| Indicator | TFIN | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 64.40 | 35.08 |
| Support Level | $60.93 | $39.61 |
| Resistance Level | $77.84 | $44.98 |
| Average True Range (ATR) | 2.32 | 2.40 |
| MACD | 0.59 | 0.18 |
| Stochastic Oscillator | 89.87 | 23.46 |
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.